Kronos Bio, Inc.
NASDAQ:KRON
0.9 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 6.288 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 4.916 | 4.463 | 4.081 | 4.866 | 0.605 | 0.16 |
| Gross Profit
| 1.372 | -4.463 | -4.081 | -4.866 | -0.605 | -0.16 |
| Gross Profit Ratio
| 0.218 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 82.343 | 93.715 | 112.903 | 43.25 | 13.446 | 5.033 |
| General & Administrative Expenses
| 41.739 | 43.4 | 38.495 | 14.794 | 3.37 | 1.612 |
| Selling & Marketing Expenses
| -3.78 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 37.959 | 43.4 | 38.495 | 14.794 | 3.37 | 1.612 |
| Other Expenses
| -0.606 | 0 | 0 | -27.408 | 0 | 0 |
| Operating Expenses
| 120.302 | 137.115 | 151.398 | 58.044 | 16.816 | 6.645 |
| Operating Income
| -118.93 | -137.115 | -151.398 | -58.044 | -16.816 | -6.645 |
| Operating Income Ratio
| -18.914 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 6.257 | 3.911 | 0.32 | -30.4 | 0.699 | -0.076 |
| Income Before Tax
| -112.673 | -133.204 | -151.078 | -88.444 | -16.117 | -6.721 |
| Income Before Tax Ratio
| -17.919 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 4.748 | -3.911 | -1.977 | -24.357 | -0.699 | -0.07 |
| Net Income
| -112.673 | -129.293 | -149.101 | -64.087 | -15.418 | -6.721 |
| Net Income Ratio
| -17.919 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.95 | -2.3 | -2.72 | -1.19 | -0.29 | -0.24 |
| EPS Diluted
| -1.95 | -2.3 | -2.72 | -1.19 | -0.29 | -0.24 |
| EBITDA
| -114.014 | -137.115 | -151.078 | -84.554 | -16.46 | -6.554 |
| EBITDA Ratio
| -18.132 | 0 | 0 | 0 | 0 | 0 |